Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice

Simple item page
dc.contributor.authorCharkoftaki, Georgia
dc.contributor.authorTan, Wan Ying
dc.contributor.authorBerrios, Pablo
dc.contributor.authorOrlicky, David
dc.contributor.authorPrakash, Jaya
dc.contributor.authorGarcia, Rolando
dc.contributor.authorAalizadeh, Reza
dc.contributor.authorThomaidis, Nikolaos
dc.contributor.authorThompson, David
dc.contributor.authorVasiliou, Vasilis
dc.date.accessioned2022-11-15T13:48:23Z
dc.date.available2022-11-15T13:48:23Z
dc.date.issued2022
dc.description.abstractAlcohol consumption is a global healthcare problem with enormous social, economic, and clinical consequences. The liver sustains the earliest and the greatest degree of tissue injury due to chronic alcohol consumption and it has been estimated that alcoholic liver disease (ALD) accounts for almost 50% of all deaths from cirrhosis in the world. In this study, we used a modified Lieber-DeCarli (LD) diet to treat mice with alcohol and simulate chronic alcohol drinking. Using an untargeted metabolomics approach, our aim was to identify the various metabolites and pathways that are altered in the early stages of ALD. Histopathology showed minimal changes in the liver after 6 weeks of alcohol consumption. However, untargeted metabolomics analyses identified 304 metabolic features that were either up- or down-regulated in the livers of ethanol-consuming mice. Pathway analysis revealed significant alcohol-induced alterations, the most significant of which was in the FXR/RXR activation pathway. Targeted metabolomics focusing on bile acid biosynthesis showed elevated taurine-conjugated cholic acid compounds in ethanol-consuming mice. In summary, we showed that the changes in the liver metabolome manifest very early in the development of ALD, and when minimal changes in liver histopathology have occurred. Although alterations in biochemical pathways indicate a complex pathology in the very early stages of alcohol consumption, bile acid changes may serve as biomarkers of the early onset of ALD.es
dc.description.versionVersión publicadaes
dc.identifier.citationCharkoftaki G, Tan WY, Berrios-Carcamo P, Orlicky DJ, Golla JP, Garcia-Milian R, Aalizadeh R, Thomaidis NS, Thompson DC, Vasiliou V. Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice. Chem Biol Interact. 2022 Jun 1;360:109931. doi: 10.1016/j.cbi.2022.109931es
dc.identifier.urihttps://doi.org/10.1016/j.cbi.2022.109931es
dc.identifier.urihttp://hdl.handle.net/11447/6667
dc.language.isoenes
dc.subjectBile Acids and Salts / metabolismes
dc.subjectEthanol / metabolismes
dc.subjectLiver Diseases, Alcoholic / pathologyes
dc.subjectMetabolomicses
dc.subjectMice, Inbred C57BLes
dc.subjectAnimalses
dc.titleLiver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in micees
dc.typeArticlees
dcterms.sourceChemico-Biological Interactionses

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Liver metabolomics identifies bile acid profile changes at early stages of.pdf
Size:
5.21 MB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services